| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/09/2008 | CN101156836A A method for forming dextran 40/ polypeptide freeze dried powder injection solution |
| 04/09/2008 | CN101156834A Ammonia temperature responsive form gel and its preparation method |
| 04/09/2008 | CN100379761C Titanium dioxide complex having molecule distinguishability |
| 04/09/2008 | CN100379756C Polyamid-oligonucleotide derivative, preparation and application of same |
| 04/09/2008 | CN100379457C Solubilization method of acyclovir in acyclovir injection liquid |
| 04/09/2008 | CN100379451C 疫苗 Vaccine |
| 04/09/2008 | CN100379450C Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
| 04/09/2008 | CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 04/09/2008 | CN100379420C Long acting slow releasing drug addiction eliminating prepn and its preparation process and use |
| 04/09/2008 | CN100379419C Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/09/2008 | CN100379408C Improved stearate composition and preparation method |
| 04/09/2008 | CN100379407C Process for manufacturing bite-dispersion tablets |
| 04/09/2008 | CN100379404C Liposome composition for reduction of liposome-induced complement activation |
| 04/09/2008 | CA2596733A1 Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 04/08/2008 | US7355012 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells |
| 04/08/2008 | US7354966 Compounds for use as surfactants |
| 04/08/2008 | US7354926 Molecules derived from noraporphine |
| 04/08/2008 | US7354913 High storage stability inhalable compositions |
| 04/08/2008 | US7354912 For therapy of osteoporosis |
| 04/08/2008 | US7354607 Honey, herb medicine extract, sweetener, vegetable cream, mixture stabilizer, emulsifier, defoamer, flavor, preservative, purified water; drink composition which makes possible to anticipate an increase of bioavailability rate due to the increase of unit surface area by powdering ultrafine particles |
| 04/08/2008 | US7354603 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 04/08/2008 | US7354602 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 04/08/2008 | US7354600 Thiolated copolymer of acrylic acid and divinyl glycol or a thiolated polymer of chitosan, sodium carboxymethylcellulose, sodium alginate, sodium hydroxypropylcellulose, hyaluronic acid, or pectin with nonterminal thiol groups; total work of adhesion of more than 120 mu J to intestinal mucosa at pH of 7 |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/08/2008 | CA2384739C Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/08/2008 | CA2304819C Perforated microparticles and methods of use |
| 04/08/2008 | CA2295588C Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 04/08/2008 | CA2274565C Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
| 04/08/2008 | CA2260909C Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 04/08/2008 | CA2231342C Pharmaceutical composition for oral delivery |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/08/2008 | CA2122732C Multivalent antigen-binding proteins |
| 04/03/2008 | WO2008039864A1 Emulsion formulations for transdermal delivery of poorly water soluble active agents |
| 04/03/2008 | WO2008039432A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | WO2008038771A1 Glutamine-containing composition for increasing blood flow |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038423A1 Antiphlogistc and analgetic composition for oral use |
| 04/03/2008 | WO2008038155A2 Controlled-release pharmaceutical tablets |
| 04/03/2008 | WO2008038134A1 Method for preparing chitosan nano-particles |
| 04/03/2008 | WO2008038111A1 Dextran functionalized with hydrophobic amino acids |
| 04/03/2008 | WO2008038106A1 Venlafaxine extended release formulations |
| 04/03/2008 | WO2008038024A1 Altered antibodies |
| 04/03/2008 | WO2008037991A1 Formulations and composites with reactive fillers |
| 04/03/2008 | WO2008037795A1 Orodispersible, gastroprotective and taste-masking formulations containing at least one gastrolesive active principle |
| 04/03/2008 | WO2008037666A1 Upar selective contrast agent for magnetic resonance imaging |
| 04/03/2008 | WO2008037604A1 Novel polybenzofulvene derivatives, synthesis and uses thereof |
| 04/03/2008 | WO2008037502A2 Olanzapine pharmaceutical composition with anhydrous lactose |
| 04/03/2008 | WO2008037484A2 Formulations comprising cyclic compounds |
| 04/03/2008 | WO2008037463A2 Means and methods of enhancing delivery to biological systems |
| 04/03/2008 | WO2008019696A3 Bisubstrate fluorescent probe binding to protein kinases |
| 04/03/2008 | WO2008016165A3 Liquid preparation |
| 04/03/2008 | WO2008013807A3 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/03/2008 | WO2008013735A3 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 04/03/2008 | WO2008013454A3 Immunogenic compounds and protein mimics |
| 04/03/2008 | WO2008006226A8 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 04/03/2008 | WO2008001204A3 Transdermal compositions of pramipexole having enhanced permeation properties |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007119028A3 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 04/03/2008 | WO2007067683A3 Methods and compositions for expanding t regulatory cells |
| 04/03/2008 | WO2007047668A3 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells |
| 04/03/2008 | US20080082156 Controlled release endoprosthetic device |
| 04/03/2008 | US20080081829 non-metallic substrate is coated with anesthetic having a proton binding site with a non-ionic form and an ionic form; bupivacaine, chloroprocaine, cocaine, lidocaine, mepivacaine, pramoxine and ropivacaine; sustained release the drug, adhesion to substrate, stable in aqueous environment |
| 04/03/2008 | US20080081801 8,13-bisvinyl-2-methyl aminocarbonylethyl-18-(3-(1-imidazolyl)propylamino)carbonyl ethyl-3,7,12,17 tetramethylporphyrin iron complex; albumin clathrate; decreases radiation resistance of hypoxic region of the tumor tissues; highly safe |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081787 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 04/03/2008 | US20080081366 Polynucleotide composition, method of preparation, and use thereof |
| 04/03/2008 | US20080081074 Polymers for functional particles |
| 04/03/2008 | US20080081062 Contacting medical device having surface formed from a swellable macromolecular substance with antibiotic such as isepamicin sulfate, amikacin sulfate, tobramycin, and/or kitasamycin tartrate; desolventizing |
| 04/03/2008 | US20080081058 Composition for Promoting Vascular Smooth Muscle Relaxation |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | DE102006046465A1 Colored organopolysiloxanes useful e.g. in cosmetic, hair care and skin care products |
| 04/03/2008 | CA2762911A1 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 04/03/2008 | CA2700579A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2700436A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2664650A1 Dextran functionalized with hydrophobic amino acids |
| 04/03/2008 | CA2664632A1 Means and methods of enhancing delivery to biological systems |
| 04/03/2008 | CA2664568A1 Formulations comprising cyclic compounds |
| 04/03/2008 | CA2663851A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | CA2661576A1 Stabilizing compositions for antibiotics and methods of use |
| 04/03/2008 | CA2654174A1 Rna nanoparticles and nanotubes |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1905456A1 Drug-containing photocrosslinked hyaluronic acid derivative gel |
| 04/02/2008 | EP1905455A1 Capsule coating composition |
| 04/02/2008 | EP1905454A1 Formulations comprising cyclic compounds |
| 04/02/2008 | EP1905453A1 Preservative composition for ophthalmic use |
| 04/02/2008 | EP1905434A1 Organic compounds comprising an S1P receptor agonist and their therapeutic use |
| 04/02/2008 | EP1905309A1 Uses of oil bodies |
| 04/02/2008 | EP1904553A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 04/02/2008 | EP1904297A2 Compositions comprising elemental metals and uses therefor |
| 04/02/2008 | EP1904183A2 Imaging and therapeutic method using monocytes |
| 04/02/2008 | EP1904109A1 Self-sterilizing products |
| 04/02/2008 | EP1904108A2 Formulation and method for administration of ophthalmologically active agents |
| 04/02/2008 | EP1904042A2 Solubilsation products of an active ingredient extract |
| 04/02/2008 | EP1904037A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 04/02/2008 | EP1904031A2 A substantially water-free pressurised propellant mixture |